<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: In New Zealand, Side Effects May Be Psychological</title>
	<atom:link href="http://www.pharmalot.com/2008/09/in-new-zealand-side-effects-may-be-psychological/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/09/in-new-zealand-side-effects-may-be-psychological/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 21:09:35 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Just A Thought</title>
		<link>http://www.pharmalot.com/2008/09/in-new-zealand-side-effects-may-be-psychological/#comment-372544</link>
		<dc:creator>Just A Thought</dc:creator>
		<pubDate>Thu, 11 Sep 2008 23:29:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15395#comment-372544</guid>
		<description>Why do the drug maker's (cough) "regultors" bother being so tight with approving new drug applications if they are going to be so loose in allowing those drugs to be changed into lessor products?
There is no way a couple of minimal studies can replace the stringent scrutiny of an innovator drug. 
This is a horrible and dangerous trend.

And to say these people are reporting more AEs because they are discussing their new reactions is diagnosing without examination.
If media coverage can be blamed for reports of AEs then they should be screaming loudly of their change to add to their defense.

 DENIAL

The big companies are burying themselves as the leaders of product quality in this industry.

The world is your lab rat.</description>
		<content:encoded><![CDATA[<p>Why do the drug maker&#8217;s (cough) &#8220;regultors&#8221; bother being so tight with approving new drug applications if they are going to be so loose in allowing those drugs to be changed into lessor products?<br />
There is no way a couple of minimal studies can replace the stringent scrutiny of an innovator drug.<br />
This is a horrible and dangerous trend.</p>
<p>And to say these people are reporting more AEs because they are discussing their new reactions is diagnosing without examination.<br />
If media coverage can be blamed for reports of AEs then they should be screaming loudly of their change to add to their defense.</p>
<p> DENIAL</p>
<p>The big companies are burying themselves as the leaders of product quality in this industry.</p>
<p>The world is your lab rat.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.148 seconds -->

